[1] American Cancer Society. Breast Cancer Facts and Figures 2017-2018. Atlanta, Ga: American Cancer Society, 2017.
[2] American Cancer Society. Cancer Facts and Figures 2018. Atlanta, Ga: American Cancer Society 2018.
[3] Siegel R, Naishadham D, Jemal. A. Cancer statistics, 2013.CA Cancer J Clin. 2013; 63 (1):11-30.
[4] Chang YC, Hsu YC, Liu CL, Huang SY, Hu MC, Cheng SP. Local anaesthetics induce apoptosis in human thyroid cancer cells through the mitogen-activated protein kinase pathway. PLoS One, 2014; 9: e89563
[5] Gomez-Gutierrez JG, Souza V, Hao HY, Montes de Oca-Luna R, Dong YB, Zhou HS, McMasters KM. Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells, Cancer Biol. Ther. 2006; 5: 875–883
[6] Sunters A, Fernández de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC, Lam EW. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J. Biol. Chem. 2003; 278: 49795–49805
[7] Fu Z, Tindall DJ. FOXOs, cancer and regulation of apoptosis. Oncogene 2008; 27: 2312–2319
[8] Barnes DM, Gillett CE. Cyclin D1 in Breast Cancer Res. Treat. 1998; 52: 1-15
[9] Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev.1999; 13: 1501-1512.
[10] Pelengaris S, Khan M, Evan G. c-MYC. more than just a matter of life and death. Nat. Rev. Cancer, 2002; 2: 764-776.
[11] Di Padova M, Barbieri R, Fanciulli M, Arcuri E, Florida A. Effect of local anaesthetic ropivacaine on the energy metabolism of Ehrlich ascites tumour cells. Oncol Res, 1998; 10:491e8.
[12] Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, Xue RF, Yuan YF, Zeng WA, Lidocaine Induces Apoptosis and Suppresses Tumour Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo. Anesthesiology, 2017; 126 (5): 868-881.
[13] Drasner K. Lidocaine spinal anaesthesia: a vanishing therapeutic index? Anesthesiology, 1997; 87: 469–472
[14] Wang HW, Wang LY, Jiang L, Tian SM, Zhong TD, Fang XM. Amide-linked local anaesthetics induce apoptosis in human non-small-cell lung cancer. J Thorac Dis 2016; 8(10):2748-2757. doi: 10.21037/jtd.2016.09.66
[15] Piegeler T, Votta-Velis EG, Liu G, Place AT, Schwartz DE, Beck-Schimmer B., Minshall RD, Borgeat A. Anti-metastatic potential of amide-linked local anaesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signalling independent of sodium channel blockade. Anesthesiology, 2012; 117 (3): 548-559.
[16] Lirk P, Berger R, Hollmann MW, Feigl H. Lidocaine time and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. Br J Anaesth, 2012; 109 (2): 200-207.
[17] Villar-Garea A, Fraga MF, Espada J, Esteller M. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res, 2003; 63:4984e9.
[18] Piegeler T, Votta-Velis EG, Liu G, Place AT, Schwartz DE, Beck-Schimmer B, Minshall RD, Borgeat A. Anti-metastatic potential of amide-linked local anaesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signalling independent of sodium channel blockade. Anesthesiology, 2012; 117 (3): 548-559.
[19] Kampo S, Ahmmed B, Zhou T, Owusu L, Anabah TW, Doudou NR, Kuugbee ED, Cui Y, Lu Z, Yan Q, Wen Q-P. Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer. Front. Oncol. 2019; 9: 21.
[20] Hirata M, Sakaguchi M, Mochida C, Sotozono C, Kageyama K, Yoshihiro K, Munetaka H, Lidocaine inhibits the tyrosine kinase activity of the epidermal growth factor receptor and suppresses proliferation of corneal epithelial cells. Anesthesiology, 2004; 100: 1206–1210.
[21] Grouselle M, Tueux O, Dabadie P, Georgescaud D, Mazat JP. Effect of local anaesthetics on mitochondrial membrane potential in living cells. Biochem J, 1990; 271: 269–272.
[22] Fraser SP, Diss JKJ, Chioni AM, Mycielska ME, Pan H, Yamaci RF, Pani F, Siwy Z, Krasowska M, Grzywna Z, Brackenbury WJ, Theodorou D, Koyuturk M, Kaya H, Battaloglu E, Tamburo De Bella M, Slade MJ, Tolhurst R., Palmieri C, Jiang J, Latchman DS, Coombes RC, Djamgoz MBA. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res, 2005; 11, 5381–5389.
[23] Le Gac G, Angenard G, Clement B, Laviolle B, Coulouarn C, Beloeil H. Local anaesthetics inhibit the growth of human hepatocellular carcinoma cells. Anesth Analg., 2017; 125 (5): 1600–9.
[24] Lee HT, Xu H, Siegel CD, Krichevsky IE. Local anaesthetics induce human renal cell apoptosis. Am J Nephrol, 2003; 23:129–139
[25] Unami A, Shinohara Y, Ichikawa T, Baba Y. Biochemical and microarray analyses of bupivacaine-induced apoptosis. J Toxicol Sci, 2003; 28: 77–94.
[26] Villar-Garea A, Fraga MF, Espada J, Esteller M. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 2003; 63: 4984–9
[27] Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg, 2006; 102: 1103–7
[28] Chang YC, Liu CL, Chen MJ, Hsu YW, Chen SN, Lin CH, Chen CM, Yang FM, Hu MC. Local anaesthetics induced apoptosis in human breast tumour cells. Anesth Analg, 2014; 118, 116–124
[29] Kawasaki C, Kawasaki T, Ogata M, Sata T, Chaudry IH. Lidocaine enhances apoptosis and suppresses mitochondrial functions of human neutrophil in vitro. J Trauma, 2010; 68: 401–408.
[30] Hodgkin AL. & Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 1952; 117: 500–544.
[31] Besson P, Driffort V, Bon É, Gradek F, Chevalier S, Roger S. How do voltage-gated sodium channels enhance migration and invasiveness in cancer cells? Biochim Biophys Acta 2015; 1848: 2493-2501.
[32] Roger S, Gillet L, Le Guennec JY, Besson P. Voltage-gated sodium channels and cancer: is excitability their primary role? Front Pharmacol 2015; 6: 152.
[33] Roger S, Potier M, Vandier C, Besson P, Le Guennec JY. Voltage-gated sodium channels: new targets in cancer therapy? Curr Pharm Des 2006; 12: 3681–3695.
[34]. Driffort V, Gillet L, Bon E, Marionneau-Lambot S, Oullier T, Joulin V, Collin C, Pagès JC, Jourdan ML, Chevalier S, Bougnoux P, Le Guennec JY, Besson P, Roger S. Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization. Mol Cancer 2014; 13: 264.
[35]. Nelson M, Yang M, Dowle AA, Thomas JR, Brackenbury WJ. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis. Mol Cancer 2015:14, 13.
[36] Yuan T, Li Z, Li X, Yu G, Wang N, Yang X. Lidocaine attenuates lipopolysaccharide-induced inflammatory responses in microglia. J Surg Res. 2014; 192(1):150–62.
[37] Brocco MC, Paulo DNS, Almeida CED, Carraretto AR, Cabral SA, Silveira AC, Gomez RS, Baptista JF. A study of interleukin 6 (IL-6) and tumour necrosis factor-alpha (TNF-α) serum levels in rats subjected to faecal peritonitis and treated with intraperitoneal ropivacaine. Acta Cirurgica Brasileira. 2012; 27:494–8.
[38] Piegeler T, Schläpfer M, Dull RO, Schwartz DE, Borgeat A, Minshall RD, Beck-Schimmer B. Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase. Br J Anaesth, 2015; 115: 784–9
[39]. Shankar S, Chen Q, Srivastava RK. Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J Mol Signal. 2008; 3:7.
[40]. Qian J, Zou Y, Rahman JSM, Lu B, Massion PP. Synergy between phosphatidylinositol 3 kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol Cancer Ther. 2009; 8: 101-9
[41] Ortega MA, Fraile-Mart′ınez O, As ′unsolo A, Buj′an J, Garc′ıa-Honduvilla N, Coca S.
Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR. Journal of Oncology 2020.
[42] Royds J, Khan AH, Buggy DJ. Update on existing ongoing prospective trials evaluating the effect of anaesthetic and analgesic techniques during primary Cancer surgery on Cancer recurrence or metastasis. Int Anesthesiol. Clin. 2016; 54 (4): e76–83.
[43] Burgering BMT, Medema RH. Decision on life and death: FOXO forkhead transcription factors are in command when PKB/Akt is off duty. Journal of leukocyte Biology, 2003; 73:689-701
[44] Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK. Resveratrol Induces Growth Arrest and Apoptosis through Activation of FOXO Transcription Factors in Prostate Cancer Cells. PLoS ONE 2010; 5: e15288
[45] Arnold A, Papanikolaou A. (2005) Cyclin D1 in breast cancer pathogenesis. J. Clin. Oncol. 2005; 23: 4215–4224.
[46] Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 2010; 10: 59–64.
[47] Datta SR., Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes DAev., 1999; 13: 2905-2927.
[48] Lirk P, Hollmann MW, Fleischer M, Weber NC, Feigl H. Lidocaine, and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth 2014; 113 (Suppl 1): i32–8
[49] Li K, Yang J, Han X. Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via the up-regulation of RARβ2 and RASSF1A demethylation. Int J Mol Sci, 2014; 15: 23519–36
[50] Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth. Analg. 2006; 102: 1103–1107.